Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02105480
Other study ID # GRZ02 (AAAPN)
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 2013
Est. completion date January 18, 2017

Study information

Verified date July 2018
Source CSD Labs GmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this double-blind pivotal clinical utility study is to determine on a large patient population whether heart murmurs can be reliably detected with high sensitivity and specificity using a locked, automated algorithm-based phonocardiogram analysis (also referred to as computer aided auscultation (CAA)).

Each patient is auscultated and diagnosed independently by a medical specialist. Additionally, for each patient, an echocardiogram is performed as the gold-standard for determining heart pathologies. The CAA results are compared to the findings of the medical professionals as well as to the echocardiogram findings.

Hypothesis: The specific (locked) CAA algorithms used in this study are able to automatically diagnose pathological heart murmurs in premature babies and newborns with at least the same accuracy as experienced medical specialists.


Description:

The following registry procedures and quality factors have been implemented:

- Quality assurance plan, including

- data validation

- proper registration procedures

- regular site monitoring

- regular auditing

- Data checks to compare data entered into the registry against predefined rules for range or consistency with other data fields in the registry.

- Source data verification to assess the accuracy, completeness, or representativeness of registry data by comparing the data to external data sources (medical records and paper case report forms).

- Standard Operating Procedures to address registry operations and analysis activities, such as patient recruitment, data collection, data management, data analysis, reporting for adverse events, and change management.

- Sample size assessment to specify the number of participants or participant years necessary to demonstrate an effect.

- Statistical analysis plan describing the analytical principles and statistical techniques to be employed in order to address the primary and secondary objectives, as specified in the study protocol or plan.

- Plan for missing data to address situations where variables are reported as missing, unavailable, "non-reported," uninterpretable, or considered missing because of data inconsistency or out-of-range results.


Recruitment information / eligibility

Status Completed
Enrollment 220
Est. completion date January 18, 2017
Est. primary completion date January 25, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 5 Days
Eligibility Inclusion Criteria:

- any premature baby or newborn

- parental approval for study participation

Exclusion Criteria:

Study Design


Intervention

Device:
Computer aided auscultation (CAA)


Locations

Country Name City State
Austria University Hospital Graz Styria

Sponsors (1)

Lead Sponsor Collaborator
CSD Labs GmbH

Country where clinical trial is conducted

Austria, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of correctly diagnosed heart murmurs through locked, independent algorithm based auscultation and traditional stethoscope based auscultation by medical experts Each patient is screened and diagnosed regarding a potential heart murmur by a medical expert through standard stethoscope based auscultation. Heart sounds are recorded using an electronic stethoscope and analyzed and diagnosed independently (with no external input) by a locked algorithm. A final diagnoses for each patient is made by a medical expert by performing an echocardiogram, the gold standard method for heart murmur detection. The diagnoses of both the medical expert and the algorithm are finally compared to the echocardiogram based diagnosis (after completion of patient recruitment). 2 years (expected)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02499419 - Exercise Capacity Evaluation in Patients With Non-rheumatic Mitral Valve Prolapse (MVP) N/A
Completed NCT02512341 - Automatic Differentiation of Innocent and Pathologic Murmurs in Pediatrics
Enrolling by invitation NCT04067635 - Primary Mitral Regurgitation Repair
Recruiting NCT06378996 - Arrhythmic Mitral Valve Prolapse Detection Using Long-term Ambulatory Rhythm Monitoring N/A
Terminated NCT03285724 - Safety and Performance Study of the Harpoon Mitral Valve Repair System N/A
Recruiting NCT03506217 - Using Pulse Counter Vigileo-Flotrac System in Transapical Off-pump Minimally Invasive Mitral Valve Repair
Completed NCT00665301 - Cardiac Output Pulmonary Arterial Catheter Compared to FloWaveâ„¢ 1000 N/A
Not yet recruiting NCT04299334 - Neochordae Technique in Mitral Valve Repair Phase 1
Completed NCT03470155 - Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function
Recruiting NCT06341166 - Multiparametric SCores for Prediction of Myocardial fIbrosis in Patients With MITral vAlve pRolapse
Completed NCT04231903 - Myocardial Protection in Minimally Invasive Mitral Valve Surgery
Not yet recruiting NCT03609931 - Patient Specific Mitral Valve Modeling for Surgical Planning and Training
Recruiting NCT05631730 - Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse Phase 3
Recruiting NCT02552771 - The Canadian Mitral Research Alliance (CAMRA) Trial CardioLink-2 N/A
Recruiting NCT01719211 - Genetic Basis of Mitral Valve Prolapse
Recruiting NCT04190602 - Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System
Recruiting NCT03113552 - Prognostic Impact of the Location of Mitral Valve Prolapse on the Long-term Results of Mitral Plasty
Recruiting NCT06255457 - Ventricular Arrhythmias in Patients Undergoing Mitral Valve Surgery
Completed NCT02771275 - Safety and Early Feasibility Study of the Harpoon Medical Device (EFS) N/A
Recruiting NCT05562804 - Mitral Valve Prolapse, Arrhythmias and Mitral Valve Surgery